|
1
|
Maiti D, Naseeruddin Inamdar M, Almuqbil M, Suresh S, Mohammed Basheeruddin Asdaq S, Alshehri S, Ali Al Arfaj S, Musharraf Alamri A, Meshary Aldohyan M, Theeb Alqahtani M, Mohammed Alosaimi T, Haran Alenazi S, Almadani ME, Ahmed S. Mulla J, Imam Rabbani S. Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity. Saudi Pharm J 2023; 31:834-844. [PMID: 37228325 PMCID: PMC10203772 DOI: 10.1016/j.jsps.2023.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2023] [Accepted: 04/06/2023] [Indexed: 05/27/2023] Open
Abstract
Background & Objectives Methotrexate (MTX) is commonly used to manage psoriasis. The drug has erratic absorption characteristics and shows several complications. The present study uses different experimental models to evaluate the solid-lipid nanoparticles of MTX (SLN-MTX) for the anti-psoriatic effect. Methods A prepared SLN-MTX formulation was used and its permeability studies were conducted on Wistar rat abdominal skin. The organ-level distribution of the drug in the formulation was tested in mice and the in-vitro anti-psoriatic activity was determined in CL-177; XB-2 keratinocytes cell lines. The efficacy of SLN-MTX formulation was compared with standard MTX and marketed MTX preparations. The results are analyzed statistically using the student's t-test. Results The data suggested that MTX from the formulation was slowly released and completely (80.36%) permeated through the skin. The flux and permeation data were found to be maximum for SLN-MTX compared to marketed and standard preparations. MTX in the formulation was found to be distributed more in the liver (67.5%) and kidney (2.34%). Further, SLN-MTX formulation showed dose-dependent inhibition on the growth of keratinocytes, and the cytotoxic concentration (CTC50) was found to be the least (518 mcg/ml). Interpretation & Conclusion The findings suggested that MTX in solid-lipid nanoparticles could be a promising formulation for the management of psoriasis since the drug was slowly released, progressively inhibited the growth of keratinocytes, and distributed mostly in organs meant for elimination. More studies in this direction might establish the precise safety and efficacy of SLN-MTX formulation in psoriasis.
Collapse
Affiliation(s)
- Debarati Maiti
- Department of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, India
| | - Mohammed Naseeruddin Inamdar
- Department of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, India
- Department of Pharmacology, East West College of Pharmacy, Bangalore, India
| | - Mansour Almuqbil
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
| | - Sarasija Suresh
- RGV Research and Innovations Pvt Ltd (RGVRI), Bangalore, India
| | | | - Sultan Alshehri
- Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia
| | - Saad Ali Al Arfaj
- King Abdulaziz Medical City in Riyadh, Ministry of National Guard, Riyadh, Saudi Arabia
| | - Ali Musharraf Alamri
- King Abdulaziz Medical City in Riyadh, Ministry of National Guard, Riyadh, Saudi Arabia
| | | | | | | | - Sami Haran Alenazi
- King Abdulaziz Medical City in Riyadh, Ministry of National Guard, Riyadh, Saudi Arabia
| | - Moneer E. Almadani
- Department of clinical medicine, College of medicine, AlMaarefa University, Dariyah, Riyadh 13713, Saudi Arabia
| | - Jameel Ahmed S. Mulla
- Department of Pharmaceutics, Shree Santkrupa College of Pharmacy, Ghogaon, Karad, Maharashtra, India
| | - Syed Imam Rabbani
- Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia
| |
Collapse
|
|
2
|
Abstract
Many scientific endeavors are dependent upon the accurate quantification of drugs and endogenous substances, such as pharmacokinetics [...]
Collapse
|